Tonix Pharmaceuticals Holding Corp.
TNXPNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $106.80M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $6.01$20.69
- Volume (live)
- -
- Avg. volume (3M)
- 743.57K
Tonix Pharmaceuticals Holding (TNXP) Stock Price & Financial Analysis
Tonix Pharmaceuticals Holding Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.02 - $6.56 |
|---|---|
| 52-Week High | $20.69 |
| 52-Week Low | $6.01 |
| Open | $6.46 |
| Volume (last close) | 929.29K |
| Average Volume (3M) | 743.57K |
| Revenue (TTM) | 29.10M |
|---|---|
| Net Income (TTM) | -159.67M |
| Free Cash Flow (TTM) | -159.89M |
| EPS (TTM) | −$12.51 |
| Profit Margin | -548.64% |
| Operating Margin | -562.75% |
| Return on Equity (ROE) | -71.83% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 106.80M |
|---|---|
| Shares Outstanding | 16.64M |
| Price to Sales (P/S) | 3.67 |
| Price to Book (P/B) | 0.48 |
| EV/EBITDA | 0.43 |
| 50-Day MA | $11.16 |
|---|---|
| 200-Day MA | $13.09 |
| 1-Year Change | −65.52% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Tonix Pharmaceuticals Holding at a Glance
As of the Oct 16, 2026 close, Tonix Pharmaceuticals Holding (TNXP) has a market capitalization of $106.80M. The stock trades at 3.7× sales. Over the trailing twelve months it lost $159.67M on revenue of $29.10M and burned $159.89M of free cash flow. Revenue grew 196.0% year over year.
As of its latest reported balance sheet, it holds $176.23M in cash and securities against $1.27M of debt, a net cash position of $174.96M.
Tonix Pharmaceuticals Holding does not currently pay a dividend.
The share price is down 65.5% over the past year. At $6.04 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $6.01 to $20.69, below its 200-day moving average of $13.09.
Frequently Asked Questions About Tonix Pharmaceuticals Holding
What is the current stock price for TNXP?
As of the Oct 16, 2026 close, TNXP stock trades at $6.04. The 52-week range is $6.01–$20.69, with a day range of $6.02–$6.56.
What is the P/E ratio for TNXP?
The P/E ratio (Price-to-Earnings) for TNXP is shown in the Key Statistics section. This valuation metric helps compare Tonix Pharmaceuticals Holding Corp. to industry peers.
Does TNXP pay dividends?
Tonix Pharmaceuticals Holding does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TNXP?
Analyst ratings and recommendations for TNXP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of TNXP?
As of the Oct 16, 2026 close, Tonix Pharmaceuticals Holding's market capitalization is $100.5M, classifying it as a micro-cap company. Tonix Pharmaceuticals Holding operates in the Healthcare sector within the Biotechnology industry.